A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

NCT04993690 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.